Loncar Cancer Immunotherapy ETF logo

Loncar Cancer Immunotherapy ETF (CNCR)

Delisted
27 May 2025
NASDAQ (NGS) NASDAQ (NGS)
$
9. 02
+0.14
+1.5766%
$
7.04M Market Cap
- P/E Ratio
7.41% Div Yield
3,077 Volume
- Eps
$ 8.88
Previous Close
Day Range
9.02 9.41
Year Range
7.88 16.27
Want to track CNCR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
4 Solid ETFs Under $20 for Your Portfolio

4 Solid ETFs Under $20 for Your Portfolio

Low-priced ETFs could be attractive for investors as these enable them to buy more shares instead of just a handful of higher-priced shares for the same amount.

Zacks | 1 year ago
Best-Performing ETF Areas of Past Week

Best-Performing ETF Areas of Past Week

Wall Street was upbeat last week on Fed rate cut hopes.

Zacks | 1 year ago
5 Top-Ranked ETFs to Buy at a Bargain

5 Top-Ranked ETFs to Buy at a Bargain

After a three-day rout, Wall Street staged a solid comeback as investors bought beaten-down stocks and recession fears eased. To tap the beaten-down prices, we have highlighted five ETFs from different corners that have declined over the past week and have a solid Zacks ETF Rank.

Zacks | 2 years ago